Close

Wasdell Group strengthens offering with Honeywood acquisition

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

By 2033, World Market For APIs Could Reach US$ 384 Billion

The worldwide active pharmaceutical ingredient market size happened to...

Market Forecast For Innovative Small Molecule Injectables

A Business Research Company report goes on to predict...

Forecast: Bioinformatics Industry Will Reach $31.71B By 2031

As per new market research that’s titled 'Bioinformatics Market...

The Wasdell Group (Wasdell), a leading outsourcing partner for companies in the pharmaceutical industry, has announced its acquisition of Honeywood Limited, a specialist manufacturer and packager located in Northampton, UK.

The acquisition will strengthen and expand Wasdell’s manufacturing and packaging capacity in the UK to support the company’s growing client portfolio.

Commenting on the announcement, Vincent Dunne, CEO of The Wasdell Group said: “We are excited to announce the acquisition of Honeywood into the Wasdell Group. Expanding our current offering is the latest step in our ongoing strategic growth plans to meet rising demand for outsourced pharmaceutical services.

“By increasing our capacity and service offerings here in the UK, we will be able better service our growing client base in the US as they look to Wasdell to provide a fully outsourced supply chain for their products within Europe.”

Bringing additional experience into the Wasdell Group, Honeywood has operated as a contract manufacturer to the pharmaceutical and healthcare industries for over 20 years.

Martin Tedham, Chairman of the Wasdell Group added: “Honeywood caught our attention due to its synergies with the existing Wasdell operations. In particular, its oral liquid manufacturing capabilities will allow us to instantly increase capacity beyond our Newcastle upon Tyne facilty to meet customer requests.

“Customers will benefit from expanded services, capacity and continuity. Honeywood’s operations will easily integrate into our current operations, and we are looking forward to collaborating with the current owners and staff moving forward.”

The acquired site will also help to maintain the group’s additional portfolio of nutraceutical clients.

This news follows the recent announcement of the group’s European headquarters in Dundalk, Ireland, a custom-built state-of-the-art facility that is set to open its doors later this month.

Honeywood Limited was advised on this transaction by Wilson Browne Solicitors. For more information on Wasdell and its solutions, visit http://www.wasdell.co.uk

About Wasdell Group
The Wasdell Group provides the pharmaceutical and nutraceutical industries with solutions to a range of outsourcing requirements. Established in 1971, with multiple sites in Europe, employing 1000 people, the group offers an impressive range of technical, manufacturing, packaging and storage and distribution services. For more information on Wasdell and its solutions, visit http://www.wasdell.co.uk

Latest stories